Additionally, TNFα-induced protein 3 (TNFAIP3, A20) has been well studied in regard to the immune response and inflammatory process in tumors, and it is postulated that TNFAIP3 may have immunomodulatory potential in GC; further research is still required to verify this [80]. This evidence concerns the gene TNFAIP3 and gastric cancer.